rs116795025
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_017950.4(CCDC40):c.1132G>A(p.Ala378Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000578 in 1,582,168 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_017950.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC40 | NM_017950.4 | c.1132G>A | p.Ala378Thr | missense_variant | 7/20 | ENST00000397545.9 | NP_060420.2 | |
CCDC40 | NM_001243342.2 | c.1132G>A | p.Ala378Thr | missense_variant | 7/18 | NP_001230271.1 | ||
CCDC40 | NM_001330508.2 | c.1132G>A | p.Ala378Thr | missense_variant | 7/11 | NP_001317437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC40 | ENST00000397545.9 | c.1132G>A | p.Ala378Thr | missense_variant | 7/20 | 5 | NM_017950.4 | ENSP00000380679 | P2 | |
ENST00000695611.1 | n.1432-2737C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00321 AC: 488AN: 152164Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000675 AC: 129AN: 191060Hom.: 1 AF XY: 0.000575 AC XY: 60AN XY: 104270
GnomAD4 exome AF: 0.000297 AC: 425AN: 1429886Hom.: 0 Cov.: 34 AF XY: 0.000241 AC XY: 171AN XY: 709098
GnomAD4 genome AF: 0.00322 AC: 490AN: 152282Hom.: 1 Cov.: 32 AF XY: 0.00312 AC XY: 232AN XY: 74466
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 06, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at